Soleus Capital Management’s Pharvaris PHVS Stock Holding History

Soleus Capital Management’s Portfolio PHVS Stock Details PHVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$19.8M	Hold	702,052	–	–	0.8%	33
2025 Q4	$19.5M	Buy	702,052 +55,000	+9%	+$1.32M	0.72%	39
2025 Q3	$16.1M	Sell	647,052 -85,916	-12%	-$1.91M	0.81%	31
2025 Q2	$12.9M	Sell	732,968 -81,684	-10%	-$1.32M	0.85%	33
2025 Q1	$12.8M	Hold	814,652	–	–	0.92%	31
2024 Q4	$15.6M	Buy	814,652 +216,483	+36%	+$4.46M	0.98%	31
2024 Q3	$11.1M	Buy	598,169 +198,739	+50%	+$3.63M	0.86%	38
2024 Q2	$7.51M	Sell	399,430 -2,471	-0.6%	-$50.3K	0.66%	48
2024 Q1	$9.29M	Buy	401,901 +184,505	+85%	+$4.9M	0.69%	44
2023 Q4	$6.1M	Sell	217,396 -126,579	-37%	-$2.56M	0.68%	42
2023 Q3	$7.18M	Sell	343,975 -47,925	-12%	-$883K	0.66%	41
2023 Q2	$5.93M	Buy	391,900 +55,000	+16%	+$532K	0.66%	44
2023 Q1	$2.71M	Buy	336,900 +26,900	+9%	+$237K	0.28%	61
2022 Q4	$3.49M	Buy	+310,000	New	+$1.63M	0.5%	47

Other funds holding PHVS

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

EFM

EQT Fund Management Luxembourg $1.02B AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Soleus Capital Management's PHVS Position: Q1 2026 in Review

Soleus Capital Management held its Pharvaris (PHVS) position steady in Q1 2026 at 702,052 shares worth $19.8M. The position accounts for 0.8% of the portfolio, ranked #33.

Soleus Capital Management first reported a position in PHVS in Q4 2022 and has held it in 14 quarters since. 110 funds tracked by Wall St. Rank hold PHVS as of Q1 2026.

Soleus Capital Management held 702,052 shares of Pharvaris worth $19.8M as of Q1 2026.
Soleus Capital Management left its Pharvaris share count unchanged in Q1 2026.
Pharvaris made up 0.8% of Soleus Capital Management's portfolio in Q1 2026, its #33 holding.
Soleus Capital Management first reported a position in Pharvaris in Q4 2022 and has held it in 14 quarters since.
110 funds tracked by Wall St. Rank held Pharvaris as of Q1 2026.

Based on Soleus Capital Management's 13F filing for Q1 2026, filed 14 May 2026.